Side-by-side comparison of AI visibility scores, market position, and capabilities
Lake Success NY financial market infrastructure (NYSE: BR) $6.1B FY2024 revenue; processes 80% of US proxy votes, 100M+ investor accounts, Itiviti acquisition, competing with Computershare and FIS.
Broadridge Financial Solutions, Inc. is a Lake Success, New York-based financial technology company — publicly traded on the New York Stock Exchange (NYSE: BR) as an S&P 500 Financials component — providing investor communications, proxy processing, regulatory compliance reporting, capital markets trading infrastructure, and wealth management technology to banks, broker-dealers, asset managers, and public companies through approximately 14,000 employees in 21 countries. In fiscal year 2024 (ending June 2024), Broadridge reported revenues of $6.1 billion and adjusted earnings per share of $8.00, with Investor Communication Solutions (ICS — proxy processing, regulatory mailings, shareholder communications for 6,000+ public companies and 100+ million investor accounts) generating the largest revenue segment and Governance, Technology and Infrastructure (GTI — fixed income trade processing, equity and derivatives clearing, wealth management platform) generating growth. CEO Tim Gokey has positioned Broadridge as mission-critical financial market infrastructure: Broadridge processes approximately 80% of all US equity proxy votes, manages post-trade operations for trillions of dollars of daily securities transactions, and operates the technology backbone of thousands of financial institutions' investor communications programs — making Broadridge as embedded in global capital markets operations as SWIFT is in international wire transfers. The 2023 acquisition of Itiviti (capital markets trading and analytics technology, $2.5 billion acquisition) expanded Broadridge's global capital markets footprint into European and Asian equities trading technology.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.